Synmosa Biopharma vs PEC: monthly revenue

Monthly revenue and year-on-year change for Synmosa Biopharma (4114) and PEC (6446) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Synmosa Biopharma ━ PEC

0%+108%-8%25/1026/0126/0426/0726/10

Monthly revenue history

MonthSynmosa BiopharmaYoYPECYoY
Oct 2026NT$766.6 million+41.2%NT$2.84 billion+102.0%
Sep 2026NT$747 million+38.7%NT$2.64 billion+100.0%
Aug 2026NT$754.3 million+49.9%NT$2.62 billion+105.4%
Jul 2026NT$791.7 million+59.8%NT$2.51 billion+92.6%
Jun 2026NT$750.9 million+30.7%NT$2.33 billion+94.9%
May 2026NT$600.8 million+12.9%NT$2.46 billion+108.5%
Apr 2026NT$570.4 million+13.5%NT$2.06 billion+68.3%
Mar 2026NT$562.6 million+17.3%NT$1.94 billion+64.4%
Feb 2026NT$430.3 million-7.8%NT$1.6 billion+56.7%
Jan 2026NT$634.9 million+25.4%NT$1.58 billion+49.8%
Dec 2025NT$543.7 million+4.3%NT$1.92 billion+69.9%
Nov 2025NT$502.6 million+0.9%NT$1.55 billion+53.0%
Oct 2025NT$543 million+9.2%NT$1.4 billion+53.6%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16